statistiche ricercatore

TANDA, MARIA LAURA PIERA

Distribuzione geografica

Continente	#
NA - Nord America	13.998
EU - Europa	6.906
AS - Asia	5.323
SA - Sud America	692
AF - Africa	129
OC - Oceania	16
Continente sconosciuto - Info sul continente non disponibili	15
AN - Antartide	1
Totale	27.080

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	13.808
IT - Italia	3.175
SG - Singapore	1.771
CN - Cina	1.251
UA - Ucraina	868
VN - Vietnam	768
HK - Hong Kong	612
SE - Svezia	607
BR - Brasile	547
DE - Germania	476
TR - Turchia	451
FI - Finlandia	330
IE - Irlanda	323
GB - Regno Unito	317
FR - Francia	275
RU - Federazione Russa	190
IN - India	126
CA - Canada	96
JP - Giappone	92
MX - Messico	79
PL - Polonia	60
AR - Argentina	49
NG - Nigeria	46
NL - Olanda	46
BD - Bangladesh	45
AT - Austria	43
CZ - Repubblica Ceca	36
ES - Italia	33
ZA - Sudafrica	33
IQ - Iraq	28
EC - Ecuador	24
BE - Belgio	23
CL - Cile	22
CH - Svizzera	21
LT - Lituania	19
PK - Pakistan	19
ID - Indonesia	18
MY - Malesia	17
IL - Israele	15
AE - Emirati Arabi Uniti	14
EU - Europa	14
UZ - Uzbekistan	14
CO - Colombia	11
RO - Romania	11
VE - Venezuela	11
NP - Nepal	10
PH - Filippine	10
MA - Marocco	9
PE - Perù	9
PY - Paraguay	9
SA - Arabia Saudita	9
AU - Australia	8
JO - Giordania	8
KR - Corea	8
NZ - Nuova Zelanda	8
KE - Kenya	7
MT - Malta	7
TN - Tunisia	7
DZ - Algeria	6
EG - Egitto	6
JM - Giamaica	5
KG - Kirghizistan	5
TH - Thailandia	5
BG - Bulgaria	4
BO - Bolivia	4
BY - Bielorussia	4
HU - Ungheria	4
MD - Moldavia	4
MK - Macedonia	4
TW - Taiwan	4
UY - Uruguay	4
AZ - Azerbaigian	3
BA - Bosnia-Erzegovina	3
CI - Costa d'Avorio	3
DK - Danimarca	3
DO - Repubblica Dominicana	3
HR - Croazia	3
IR - Iran	3
KZ - Kazakistan	3
PT - Portogallo	3
RS - Serbia	3
SN - Senegal	3
AL - Albania	2
BH - Bahrain	2
CG - Congo	2
EE - Estonia	2
ET - Etiopia	2
GR - Grecia	2
GT - Guatemala	2
HN - Honduras	2
KW - Kuwait	2
SK - Slovacchia (Repubblica Slovacca)	2
SR - Suriname	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
AO - Angola	1
AQ - Antartide	1
BS - Bahamas	1
BZ - Belize	1
GA - Gabon	1
Totale	27.064

Salva come PNG Salva come JPEG

Città	#
Milan	2.087
Fairfield	1.409
Ashburn	1.246
Dallas	1.228
Singapore	1.041
San Jose	1.029
Woodbridge	831
Chandler	737
Jacksonville	684
Houston	673
Hong Kong	596
Seattle	566
Wilmington	527
Cambridge	451
Dearborn	367
Ann Arbor	354
Nyköping	322
Dublin	306
Beijing	304
Princeton	302
The Dalles	234
Izmir	216
Boardman	212
Lauterbourg	184
Rome	184
Chicago	177
Dong Ket	164
Los Angeles	162
New York	150
Helsinki	132
Ho Chi Minh City	132
Hanoi	111
Como	105
San Diego	102
London	96
San Mateo	78
Tokyo	77
São Paulo	75
Munich	74
Orem	73
Council Bluffs	69
Guangzhou	65
Santa Clara	63
Ogden	60
Washington	58
Frankfurt am Main	53
Warsaw	51
Shanghai	50
Redmond	48
Abuja	45
Chennai	43
Mexico City	42
Hefei	41
Montreal	36
Varese	34
Brno	33
Kunming	33
Toronto	32
Denver	31
Manchester	31
Buffalo	30
Phoenix	29
Atlanta	27
Düsseldorf	26
Haiphong	26
San Francisco	26
Vienna	26
Johannesburg	25
Nuremberg	25
Poplar	25
Brooklyn	23
Turku	23
Brussels	22
Amsterdam	21
Nanjing	21
Norwalk	21
Salt Lake City	21
Stockholm	21
Paris	20
Cavaria con Premezzo	19
Shenzhen	19
Da Nang	18
Belo Horizonte	17
Berlin	17
Jinan	17
North Bergen	17
Tampa	17
Tianjin	17
Hangzhou	16
Boston	15
Istanbul	15
Elk Grove Village	14
Mumbai	14
Zhengzhou	14
Ankara	13
Charlotte	13
Turin	13
Des Moines	12
Falkenstein	12
Tashkent	12
Totale	19.495

Salva come PNG Salva come JPEG

Nome	#
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy	302
Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma	257
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study	253
Simultaneous medullary and papillary thyroid cancer: two case reports.	247
Graves' ophthalmopathy	247
Epidemiology, natural history, risk factors, and prevention of graves’ orbitopathy	244
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management	243
The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study	241
Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved?	239
Masked hypertension in newly diagnosed hypothyroidism: a pilot study	239
Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role?	237
Disease heterogeneity in IgG4-related hypophysitis: report of two histopathologically proven cases and review of the literature	228
Breast cancer and thyroid diseases: analysis of 867 consecutive cases	225
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study	223
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European Endocrinologists	218
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	218
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity	215
Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy?	214
Pituitary apoplexy during pregnancy: A rare, but dangerous headache	213
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial	209
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?	208
Outcome prediction of treatment of Graves' hyperthyroidism with antithyroid drugs	207
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe	207
Nutrizione iodica e ipertiroidismo: quello che c’è da sapere	206
Continuous monitoring of the recurrent laryngeal nerve in thyroid surgery: a critical appraisal	206
Can a patient-tailored treatment approach for Graves' disease reduce mortality?	206
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study	205
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study	198
Multidisciplinary Management of Intrathoracic Goiter: A Case Report	197
Minimally invasive follicular thyroid cancer (MIFTC) - A consensus report of the European Society of Endocrine Surgeons (ESES)	196
Thyroid cancer with tracheal invasion: A pathological estimation	196
Time interval in diagnosis and treatment of papillary thyroid cancer: a descriptive, retrospective study	196
Physical performance in newly diagnosed hypothyroidism: a pilot study	195
Plasma total and acylated ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction	194
Case report: multiple electrolyte disturbance with severe neurological manifestations induced by chronic use of PPIs	193
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal	193
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)	193
Skeletal health in patients with differentiated thyroid carcinoma	190
Medullary thyroid carcinoma: surgical treatment advances	189
Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association	187
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group	187
An update on medical management of Graves' ophthalmopathy	186
Thyroid hormone treatment for differentiated thyroid carcinoma: What drug, how long, what dose?	186
Iodine supplementation in women of reproductive age: a survey of clinical practice among Italian gynecologists and midwives	185
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment	185
Novel treatment modalities for Graves' orbitopathy	183
The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study	180
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.	179
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center	178
Shortening Hospital Stay for Thyroid Surgery.	175
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels:studies in vivo by color flow Doppler sonography	173
Analisi dei costi	172
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy	168
Orbital radiotherapy for Graves' ophthalmopathy	167
An update on the pharmacological management of hyperthyroidism due to Graves' disease	167
Pituitary in black—hypopituitarism secondary to hemosiderosis	167
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study	166
Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy	165
Medullary thyroid carcinoma: surgical treatment advances	163
Amyloid goiter	163
Amiodarone and the thyroid	162
Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study	162
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment	162
Amiodarone-unduced thyrotoxicosis. A review	161
Management of thyroid eye disease	160
Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines. A Longitudinal Study in Differentiated Thyroid Carcinoma during Short-Term Hypothyroidism and Thyroid Hormone Replacement.	160
Gastric Xanthomatous Hyperplastic Polyps – Just an Incidental Endoscopic Finding?	160
Radioiodine and thyroid-associated ophthalmopathy	159
Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature	159
Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists' perspectives.	159
Treating Graves' orbitopathy: where are we?	158
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease	158
Orbital radiotherapy for Graves' ophthalmopathy	157
Thyroid autoimmunity and environment	157
Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions	157
Iopanoic acid rapidly controls Type I amiodarone-induced thyrotoxicosis prior to thyroidectomy	154
Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications	154
Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations	154
Efficacy and safety of orbital radiotherapy for Graves' orbitopathy	154
Recent developments in the follow-up, prevention and management of complications in thyroid surgery	153
Relationship between management of hyperthyroidism and course of the ophthalmopathy	152
Novel approaches to the management of Graves' ophthalmopathy	152
La prevenzione dell'oftalmopatia basedowiana	151
Cigarette smoking and the thyroid	151
Orbital radiotherapy for Graves' ophthalmopathy	150
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?	149
Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying	149
Smoking and the Thyroid	148
Position statement of the Microbiota International Clinical Society	147
Cigarette smoking and treatment outcomes in Graves' ophthalmopathy	147
Orbital decompression in Graves' ophthalmopathy by medial and lateral wall removal	146
When primary hyperparathyroidism comes as good news	146
Novel immunomodulating agents for Graves orbitopathy	144
Solitary intrathyroidal metastasis of renal clear cell carcinoma in a toxic substernal multinodular goiter.	144
Currently available somatostatin analogs are not good for Graves' orbitopathy	143
Prevalence and natural history of Graves' orbitopathy in the XXI century	143
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	140
Image-guided thyroid nodule ablation: technical notes and critical appraisal	139
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	135
SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review	135
Totale	18.240

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	108.701
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	108.701

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	781	0	0	0	0	0	0	0	0	0	170	243	368
2021/2022	1.829	176	169	89	71	111	139	117	88	246	291	128	204
2022/2023	2.201	272	139	170	230	158	486	16	265	264	82	52	67
2023/2024	3.560	531	536	544	653	643	333	19	41	95	46	17	102
2024/2025	2.905	14	26	435	126	100	145	135	210	306	230	366	812
2025/2026	8.510	624	737	998	1.184	800	484	1.791	581	859	452	0	0
Totale													27.391